BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19882304)

  • 1. To bridge or not to bridge: that is the question. The argument FOR bridging therapy in patients on oral anticoagulants requiring temporary interruption for elective procedures.
    Spyropoulos AC
    J Thromb Thrombolysis; 2010 Feb; 29(2):192-8. PubMed ID: 19882304
    [No Abstract]   [Full Text] [Related]  

  • 2. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.
    Douketis JD; Healey JS; Brueckmann M; Eikelboom JW; Ezekowitz MD; Fraessdorf M; Noack H; Oldgren J; Reilly P; Spyropoulos AC; Wallentin L; Connolly SJ
    Thromb Haemost; 2015 Mar; 113(3):625-32. PubMed ID: 25472710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin?
    Jaff MR
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S17-21. PubMed ID: 19213061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periprocedural bridging anticoagulation: current perspectives.
    Palaniswamy C; Selvaraj DR
    Am J Ther; 2011 Jul; 18(4):e89-94. PubMed ID: 20228672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin.
    Malato A; Saccullo G; Lo Coco L; Caramazza D; Abbene I; Pizzo G; Casuccio A; Siragusa S
    J Thromb Haemost; 2010 Jan; 8(1):107-13. PubMed ID: 19817996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin Bridging Therapy for Patients on Chronic Oral Anticoagulants in Periprocedural Settings.
    Nikolakopoulos I; Spyropoulos AC
    Semin Thromb Hemost; 2020 Feb; 46(1):26-31. PubMed ID: 31830765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Perioperative conversion of oral anticoagulants to heparin (bridging) in ophthalmic medicine].
    Feltgen N; Pielen A; Hattenbach LO; Geisen U; Heinz J
    Ophthalmologe; 2010 Jul; 107(7):636-40. PubMed ID: 20024560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic dosage in half bridging?].
    Emter M
    Ophthalmologe; 2010 Sep; 107(9):861; author reply 861-2. PubMed ID: 20811749
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of the concomitant use of heparin on the effects of warfarin during catheter ablation for atrial fibrillation.
    Inada K; Matsuo S; Tokutake K; Yokoyama K; Hioki M; Narui R; Ito K; Tanigawa S; Yamashita S; Tokuda M; Shibayama K; Miyanaga S; Sugimoto K; Yoshimura M; Yamane T
    Heart Vessels; 2016 Mar; 31(3):397-401. PubMed ID: 25471944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging with enoxaparin using a half-therapeutic dose regimen: safety and efficacy.
    Klamroth R; Gottstein S; Essers E; Landgraf H
    Vasa; 2010 Aug; 39(3):243-8. PubMed ID: 20737383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bridging therapy and oral anticoagulation: current and future prospects.
    Spyropoulos AC
    Curr Opin Hematol; 2010 Sep; 17(5):444-9. PubMed ID: 20613508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
    Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
    Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tonsillectomy in the anticoagulated patient.
    Cole SM; Patterson MB; Cupp CL
    Ann Otol Rhinol Laryngol; 2007 Aug; 116(8):589-93. PubMed ID: 17847726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periprocedural heparin bridging in patients receiving oral anticoagulation: a systematic review and meta-analysis.
    Yong JW; Yang LX; Ohene BE; Zhou YJ; Wang ZJ
    BMC Cardiovasc Disord; 2017 Dec; 17(1):295. PubMed ID: 29237411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative management of warfarin therapy: to bridge or not to bridge, that is the question.
    Douketis JD
    Mayo Clin Proc; 2008 Jun; 83(6):628-9. PubMed ID: 18533078
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy Insight: management of urology patients taking long-term warfarin anticoagulation therapy.
    Daniels PR
    Nat Clin Pract Urol; 2005 Jul; 2(7):343-50. PubMed ID: 16474787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Antithrombotic Agents During Surgery or Other Kinds of Medical Procedures With Bleeding: The MARK Study.
    Gotoh S; Yasaka M; Nakamura A; Kuwashiro T; Okada Y
    J Am Heart Assoc; 2020 Mar; 9(5):e012774. PubMed ID: 32079478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periprocedural management of oral anticoagulation in patients with atrial fibrillation: approach in the era of new oral anticoagulants.
    Healey JS; Brambatti M
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S54-9. PubMed ID: 23790599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.
    Douketis JD; Spyropoulos AC; Kaatz S; Becker RC; Caprini JA; Dunn AS; Garcia DA; Jacobson A; Jaffer AK; Kong DF; Schulman S; Turpie AG; Hasselblad V; Ortel TL;
    N Engl J Med; 2015 Aug; 373(9):823-33. PubMed ID: 26095867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation interruptus: not without risk.
    Ezekowitz MD
    Circulation; 2004 Sep; 110(12):1518-9. PubMed ID: 15381656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.